Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma presenting with obstructive jaundice.

Eric C H Lai1, Wan Yee Lau

  • 1Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.

ANZ Journal of Surgery
|July 4, 2006
PubMed
Summary

Jaundice in hepatocellular carcinoma (HCC) patients requires differentiating causes. Icteric type HCC with biliary obstruction shows improved survival with resection or palliative care, unlike hepatocellular type HCC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the Institute Mutualiste Montsouris system for the stratification of laparoscopic liver resections: an international multicenter study.

Hepatobiliary surgery and nutrition·2026
Same author

Laparoscopic approach reduces the incidence of postoperative pulmonary complications after hepatectomy for hepatocellular carcinoma: a multicenter overlap propensity score-weighted analysis.

Hepatobiliary surgery and nutrition·2026
Same author

The future of hepatobiliary surgical oncology.

Hepatobiliary surgery and nutrition·2025
Same author

Defining Global Benchmarks for Robotic Liver Resections: An International Multicenter Study.

Annals of surgery·2025
Same author

Validation of the Iwate scoring system for the stratification of laparoscopic liver resections: An international multicenter study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma.

eGastroenterology·2025

Area of Science:

  • Hepatology
  • Oncology
  • Gastroenterology

Background:

  • Jaundice affects 5-44% of hepatocellular carcinoma (HCC) patients.
  • The cause of jaundice in HCC influences treatment and prognosis.
  • This review categorizes, manages, and discusses the prognosis of HCC patients with jaundice.

Purpose of the Study:

  • To review the classification of jaundice in HCC.
  • To outline management strategies for HCC-associated jaundice.
  • To analyze the prognosis of HCC patients presenting with jaundice.

Main Methods:

  • Medline search using keywords: 'hepatocellular carcinoma', 'jaundice', 'tumour thrombus'.
  • Manual reference search of key identified articles.

Main Results:

Related Experiment Videos

  • Hepatocellular jaundice indicates a poor prognosis.
  • Icteric type HCC (biliary obstruction) shows 1-, 3-, and 5-year survival rates of 57.1-100%, 20-47%, and 6.7-45% post-resection.
  • Palliative biliary drainage alone yields <6 months survival; combined palliative treatment extends survival to ~1 year.

Conclusions:

  • Distinguishing hepatocellular from icteric types of HCC is crucial.
  • Curative resection offers survival comparable to non-jaundiced HCC patients in the icteric type.
  • Palliative treatment improves quality of life and survival for unresectable icteric HCC.